Biotech Firm Galapagos to Split Into Two Entities, Cut Jobs
Belgian biotech company Galapagos NV plans to spin off part of its operations, creating a new listed firm with approximately ...
Morgan Stanley Sticks to Their Hold Rating for Galapagos (GLPG)
In a report released today, Judah Frommer from Morgan Stanley maintained a Hold rating on Galapagos (GLPG – Research Report), with a price ...
STAT6d
Galapagos to split itself into two companies as part of turnaround plan
The beleaguered Belgian firm Galapagos is splitting itself into two companies, with the brandname biotech prioritizing ...
Galapagos Unveils 2025 Split To Accelerate Innovation, Sharpen Strategic Focus
Galapagos NV plans to split into two entities by mid-2025, focusing on oncology cell therapy and innovative medicines, with ...
Galapagos to Unlock Shareholder Value by Declaring its Intent to Separate into Two Publicly Traded Entities
Galapagos intends to create a new company with approximately €2.45 billion in cash dedicated to building a pipeline of innovative medicines through transformational transactions Galapagos will gain ...
Galapagos NV: Galapagos to Unlock Shareholder Value by Declaring its Intent to Separate into Two Publicly Traded Entities
Galapagos intends to create a new company with approximately €2.45 billion in cash dedicated to building a pipeline of innovative medicines through transformational transactions Galapagos will gain ...
ETF Daily News3d
Galapagos (NASDAQ:GLPG) Shares Gap Down – Should You Sell?
Galapagos NV (NASDAQ:GLPG – Get Free Report) gapped down before the market opened on Friday .The stock had previously closed at $28.17, but opened at $27.00. Galapagos shares last traded at $26. ...
Barclays Keeps Their Hold Rating on Galapagos (0JXZ)
In a report released today, Emily Field from Barclays maintained a Hold rating on Galapagos (0JXZ – Research Report), with a price target of ...